Documente Academic
Documente Profesional
Documente Cultură
in 10-14days.
ocyte globulin)
ncer and Hodgkin's. Lytic from MM, non-small cell lung cancer and non-Hodgkin's. Both from breast.
mide is a prokinetic central and peripheral D2 receptor blocker, ondansetron is a 5HT3 serotonin receptor antagonist and aprepitant
meter <10 mm and thickness < 3mm = follow up in 3 months and then every 6 months. Symptomatic, diam 10 mm or more, thicknes
onin release assay (Gold std), heparin induced platelet aggregation assay and heparin-PF4 antibody ELISA.
oncentric, laminated, central, diffuse homogenous.
hat inc. Hb F
isease with some beta chains. Hence HbA and HbS are both present. Type 1 has 3-5% HbA, Type 2 has 8-14% HbA and Type 3 has 1
al of ferrous sulphate with vit c assuming it is IDA.
meningococcus. H. influenza
of all the heart structures. Complications are 1) myocardial ischemia/infarct 2) restrictive cardiomyopathy with diastolic dysfunction
n fraction, thus leading to dilated cardiomyopathy.
os,vitiligo etc
, cyclophosphamide
c irradiation, chemical exposure
nal size with a difference of >1.5 cm, abdominal bruit
n-contrast MR angiography
nitrate to nitrite
axes the ureters
ase 2) microscopic hematuria with no evidence of glomerular disease or infection but increased risk for malignancy 3) recurrent UTI
m with contrast. Lower = Cystoscopy
pertonic saline 3%
is - no RBCs seen on microscopy 2) march hemoglobinuria from RBC trauma - RBC casts seen 3) exercise induced hematuria - dx of e
PR interval and QRS complex > disappearance of P waves > sine wave.
inol,hydration,resburicase
nsvaginal USG 4) treat empirically for stone + observe OR MR urogram OR low dose CT urogram (only in 2nd and 3rd trimester)
nal failure, complete obstruction 2) stone size 10mm or more 3) despite medical management, pt. has uncontrolled pain OR no ston
betes, gestational hypertension
phrectomy. Stage 2 = extends through capsule but not beyond Gerotas fascia = radical nephrectomy. Stage 3 = invasion of major VV, a
lp slow progression.
or malignancy 3) recurrent UTIs 4) obstructive symptoms with suspicion for stricture, stone 5) irritative symptoms without urinary
tage 3 = invasion of major VV, abdominal LN, adrenal glands = radical + consider debulking, chemo and immuno therapies.
n/methanol/ethylene glycol/isopropranolol.
hanical ventilation
gram stain and culture,with an atypical C-Xray
nights or less a month nighttime, rx with step 1. Mild persistent is > 2 days a week but not daily SABA use, 3-4 nights a month, rx wi
3: Add (low dose ICS + LABA) OR medium dose ICS. Step 4: Add (medium dose ICS + LABA). Step 5: Add (high dose ICS + LABA) AND
ractions, cyanosis, diaphoresis, exhaustion or extreme fatigue, marked tachycardia, pulsus paradoxus, pco2 42 or more, peak expirato
eral opacities....CT-Scan findings...bronchial wall thickening
ars, annually
im on Mechanical vent.
more than 30breaths/min,B.P. less than 90mmhg and age-65yrs
above, Neb or inhaled albuterol, inhaled ipratropium > oral prednisone > MgSO4 or terbutaline > intubation
preg and > 40 in non-pregnant
cavitary, pregnancy
matic patient, give methacholine and if PEFR or FEV1 decreases by 20% or more
A use, 3-4 nights a month, rx with step 2. Moderate persistent: daily SABA use, >1 night a week but not every night, rx with step 3. Sev
d (high dose ICS + LABA) AND consider omalizumab for patients with allergies. Step 6: Add (high dose ICS + LABA + oral prednisone
pco2 42 or more, peak expiratory flow PEF <25%, confusion and drowsiness, depressed respiratory drive, severe hypoxemia
> intubation
SIRS. 2 + infection = sepsis. 2 + infection + organ dysfunction = severe sepsis. 2 + infection + organ dysfunction + hT = septic shock
every night, rx with step 3. Severe persistent: throughout the day, 4-7 nights a week, rx with step 4 or 5
e ICS + LABA + oral prednisone) AND consider omalizumab for patients with allergies.